Background and objective: Serological screening enables us to detect patients of celiac disease (CD) before they develop serious complications. This study was planned to assess the prevalence of CD in the family members of index cases by serological screening. Patients and Methods: A prospective study was conducted on 50 children diagnosed to be having CD. Serological screening of the family members of index cases was done and those showing positivity for the screening tests were further subjected to endoscopic duodenal biopsy for histopathological examination. Results: A total of 164 members of 50 celiac families were initially screened for antibodies. Antibody picked up 32.9% by IgG anti-gliadin (AGA), 20.7% by endomysial antibody, 19.5% by tissue transglutaminase and 14.6% IgA AGA as seropositive for CD. Endoscopic findings characteristics for CD were present in only eight family members. Conclusion: Family members of CD cases represent potential cases of CD.
Introduction
Celiac disease (CD) also known as gluten sensitive enteropathy is characterized by inflammation of small intestinal mucosa that results from a genetically based immunological tolerance to ingested gluten. Many CD cases are undiagnosed because they have atypical clinical presentation or are asymptomatic. They carry the long term risk of complications like infertility, anemia, osteoporosis and gastrointestinal lymphoma.
Screening has been used for evaluation in mass or population based studies as well as in case finding. Population based studies have shown prevalence of undiagnosed cases up to 4% in Europe [1] . Serological screening methods described for investigating CD appear more important since the spectrum varies from active, treated, silent, latent and potential cases [2] . This made non-invasive methods essential for preliminary diagnosis before it can be established by small intestinal biopsy. The disease has a genetic basis, requiring the presence of speciEc HLA alleles that encode for DQ2 and DQ8 [3] . As a result, CD occurs in families [4] and screening family members can account for a signiEcant percentage of newly diagnosed patients [5] . Therefore a prospective study was conducted to define the prevalence of disease in the family members of index diagnosed cases of CD.
Patients and Methods
Fifty index patients of CD diagnosed by modified ESPGHAN (European Society for Pediatric Gastroenterology, Hepatology and Nutrition) criteria who were undergoing treatment in the division of Pediatric Gastroenterology, Post Graduate Institute Medical Education and Research, Chandigarh, India were studied over a period of 1 year.
Serological screening of the family members (father, mother, brother and sister) of these index cases was done after taking informed consent. The family members showing positivity for any one of the serological tests were further subjected to endoscopic duodenal biopsy for histopathological examination while those seronegatives for CD were excluded from study ( Fig. 1) .
All the subjects were studied for baseline demographic and social profile. Their detailed history and physical examination were recorded on pretested proforma. All patients underwent hemoglobin, total leukocyte count, differential leukocyte count, platelet count, reticulocyte count and peripheral smear for the type of anemia, liver function tests including serum bilirubin, alanine aminotransferase/aspartate aminotransferase (AST/ALT), serum alkaline phosphatase, serum proteins D-xylose test, serum calcium, serum phosphorus and celiac serology.
Anti-tissue transglutaminase (tTG) levels were done using DRG tTG-A ELISA REF EIA-10 503 kit provided by The Binding Site Ltd (UK) with both positive and negative controls. This test is based on recombinant human tTG as antigen. Reference cut off of anti-tTG IgA by above kit was 15 Uml À1 . In case of clinical setting but serology negative, immunoglobulin A levels were done.
Anti-gliadin IgA (AGA) and IgG were analyzed by indirect solid phase enzyme immunometric assay by ELISA (BL diagnostika kit, Germany Cat no 5B40L) method. Detection of anti-endomysial antibody (EMA) was based on the principle of indirect immunofluorescence assay (IFA). Upper GI endoscopic biopsy was performed using GIF 160 Olympus endoscope. Patients received injection ketamine 1 mgkg
À1
of body weight as premedication. Endoscopic markers were evaluated for grooving/scalloping of the duodenal folds, mosaic pattern of the mucosa, nodularity and reduction and thinning in the numbers (<3-fold in straight line on endoscopic vision or absence of Kerkring folds at maximum insufflation.
Biopsy specimens comprising of at least three fragments with a forceps (open cup $6 mm) were taken. Samples were carefully oriented on filter paper and fixed in 10% formalin. Histopathology was expressed according to the Marsh classification 1992. After confirming the diagnosis, all the patients and their parents were counseled for gluten-free diet (GFD) by the trained dietician. They were given iron and folic acid supplementation and followed up in CD clinic at our institute.
Statistical analysis
Chi-square, p-value, sensitivity, specificity, predictivity, positive predictive value, negative predictive value, mean and standard deviation were used for analyzing the data.
Ethical consideration
Ethical clearance was taken from Institute ethical committee. Family screening of CD index cases was done by serological tests of the family members of index case after well informed written consent. The collected blood samples were utilized for serological tests i.e. IgA and IgG-AGA, IgA EMA and IgA tTG antibodies to detect unrecognized celiacs in these family members. Those who were serologically positive on above screening were called back and subjected to routine blood test (hemogram and liver function tests), malabsorptive work up (D-xylose) and UGI endoscopy with biopsy after informed consent.
Results
In these 50 index cases the mean age, age of onset of symptoms, age of presentation were 7.44 AE 2.82, 3.46 AE 1.82 and 6.42 AE 2.30 years, respectively. There was a male preponderance (2.3:1). The clinical profile of the index cases depicted failure to thrive (100%) and chronic diarrhea (84%) as the most common symptoms. Those not presenting as chronic diarrhea had refractory anemia, short stature and constipation. On investigation, the index cases of CD showed anemia in all, sub grouped as mild to moderate in 43/50 (86%) and severe in 7/50(14%) patients. The mean hemoglobin levels were 8.60 AE 1.45 gdl
À1
. D-xylose a marker of mucosal malabsorption was abnormal in 47/50 (94%) CD cases. The mean value of D-xylose level was 0.60 AE 0.26 g/ 5 g/5 h in the urine. Antibody type was done differently for the index cases depending upon the treating physician. The collected data revealed that 18 underwent IgA AGA, 14 tTG and 18 IgA EMA as a part of their serology work up for CD. Out of 50, 4 had seronegativity for CD, two for IgA AGA and the other two for EMA while the rest showed seropositivity for the antibody type done as selected by the treating physician. These four patients were later found to have IgA deficiency. The histomorphology of the index cases on mucosal biopsies revealed normal villi with increased intra epithelial lymphocytes (IEL) in 13/50 (26%), partial villous atrophy (PVA) in 3/50(6%) and subtotal villous atrophy (SVA) in 24/50 (68%). The flowchart (Fig. 2) shows the seropositivity trend for CD in the family members of 50 index cases of CD. Of the 50 families serologically screened 14 families comprising 39 family members were negative and were excluded from the study. In the remaining 36 families consisting of 125 members, 76/125 had seropositivity for at least any one antibody type while 49/125 were seronegatives and they were also excluded from study. Of the 76 seropositive only 30 family members underwent endoscopic duodenal biopsies followed by histomorphology. Sixteen declined to give consent for work up while 30 others did not turn up for follow up.
In 164 family members serologically screened there were 64 siblings and 100 parents. Of the 64 siblings, 39 were brothers and 25 sisters of the index cases (Table 1 ). In the 30 seropositive family members who completed the study it included 18 parents, i.e. 7 fathers and 11 mothers along with 12 siblings i.e. four brothers and eight sisters of the index CD cases. Females outnumbered males by ratio of 1.5:1. Of the 30 seropositive family members 20 were asymptomatic while the other 10 had dyspepsia, recurrent abdominal pain, failure to thrive, anemia and irritable bowel syndrome (diarrhea predominant type) as presenting symptoms ( Table 2) . Out of the 30 seropositive eight family members had endoscopic markers of CD in the form of scalloping and decreased folds. Seven family members had anemia with mean hemoglobin levels as 10.65 (range 10-11) g dl
. In three of these seven family members all the four antibodies were positive. D-xylose was abnormal in two family members, while increased transaminases were present in one. Six family members did not turn up to undergo D-xylose test (Table 3) . Thus, a total of 164 family members were serologically screened and of them 76 had seropositivity for at least one antibody type for CD. The antibody positivity on screening revealed IgG AGA in 32.7%, IgA AGA in 14.6%, IgA EMA in 20.7% and tTG in 19.6% out of the 164 members screened (Table 4) family members had all four antibodies positive in the 30 serum analyzed. Of the 30 family members who showed seropositivity for CD none had partial or subtotal villous atrophy on histology. All showed increase in IEL of varying severity i.e. þ to þþþ along with crypt hyperplasia. Twelve were IgA AGA seropositive while 18 were seronegative. Statistical significance was present when histologically Group 1 i.e. þ and þþ and Group 2 (þþþ) were compared with seropositivity for IgA AGA in predicting gluten sensitivity. This has been shown in Table 5 . Similarly for IgG AGA, IgA tTG and IgA EMA status has respectively been given (Table 5) following the same histological grouping. All the family members who had clinical symptoms stopped taking gluten of their own as their siblings were doing. Their symptoms improved and their health parameters improved in follow up. Their antibody titers decreased remarkably on GFD when tested on follow up.
Discussion
The clinical presentation of CD depends upon the severity and extent of small intestinal pathology. In our 50 index CD cases there was male preponderance (2.3:1) contrary to the female preponderance (3:1) reported in western literature [6] . In our index cases, the mean age of onset of symptoms was 3.4 years, while age of presentation with the disease was 6.4 years. Kumar et al. showed the same to be 4 and 9.2 years, respectively [7] . Delay in the age of presentation could probably be due to either delayed weaning, late introduction of gluten, delayed referral or lack of awareness of the disease.
The clinical profile of our index cases showed failure to thrive and chronic diarrhea as the most common symptoms present in 100 and 84%, respectively. Western series have shown it in variable percentages [8] . Some of our cases presented with refractory anemia (8%) and short stature (6%). This highlights that CD should be suspected not only in patients presenting predominantly as gastrointestinal symptoms in the form of malabsorption but also in those with extra intestinal features like refractory anemia and short stature. The duodenal mucosal histology (as per Marsh's spectrum) had 26% cases in the infiltrative stage, 6% had partial villous atrophy while 68% represented the flat destructive stage of mucosal disease. In all the cases serology like IgA AGA, tTG and EMA showed positivity except in four cases. These four seronegative cases, who were IgA deficient, had subtotal villous atrophy on histology and they improved on GFD.
IgG AGA was found to be the most common antibody in the family members screened. The sensitivity and specificity of IgG AGA is low both in children and adults compared to EMA and tTG [9] . Low titers of antibodies to gliadin are present in general population or healthy adults due to gluten sensitization. The antibody positivity pattern in the family members was not uniform. There were different combinations of antibody pattern, 7/30 showed positivity for all four antibodies, 3 showed combination of three antibodies, 7 had any combination of two antibodies and 12 family members had anyone antibody positive. Cataldo screened 599 first degree relatives of CD for IgA AGA, IgA EMA and IgG AGA and found 7.6, 9.5 and 15.5% respectively to be seropositive [10] . Our figures are slightly higher compared to them. On upper gastrointestinal endoscopy, 8/30 members showed changes of CD in the form of scalloping and decreased number or thinning of mucosal folds. On histopathology of duodenal mucosa they showed increased IELs and crypt hyperplasia. Out of the 30 members, 16 had mild (þ), 8 had moderate (þþ) while 6 had severe (þþþ) increase in intra-epithelial cells in mucosal biopsies. When comparing between the three groups with antibody positivity there was no significant difference. But by combining above mild and moderate groups and comparing with severe, antibody positivity pattern was seen. In our data an increase in IEL above 60/100 epithelial cells, could possibly be related to gluten sensitivity in an asymptomatic family member. In view of the small size of the data analyzed we can not comment categorically on the same. This pattern was seen in six family members in whom all four antibodies were positive and three of them had endoscopic markers of CD. In literature people have specified 40 IEL/100 epithelial cells as a significant finding for gluten sensitivity. Marsh found 38% of the first degree relatives of CD to have increase in IEL above normal in small bowel mucosal biopsies. These relatives had a highly significant association with HLA DR3 compared to matched controls but other serological markers were not studied in these members [11] . Therefore, there are subsets of family members who belong to a subclinical stage (possibly potential) who are asymptomatic with normal villous structure however show Iymphoplasmacytic infiltration and an increase in the IEL. Ten of our family members were put on GFD as they had some symptoms which disappeared after GFD. A follow up of family members who are seropositive but asymptomatic may be advisable to look for development of flat destructive lesions classical of overt CD. It was not possible for us to measure the sensitivity, specificity and negative predictive value of serological markers used because family members who were seronegative on screening were excluded from the study and they did not undergo duodenal biopsy to look for mucosal changes.
We conclude that the answer to the above problems of asymptomatic family members screened can only be found on long-term follow up studies by serial serology and histomorphology of the small bowel mucosa.
